Jump to content

Hepatitis A and typhoid vaccine

From Wikipedia, the free encyclopedia
(Redirected from Hepatyrix)
Hepatitis A and typhoid vaccine
Combination of
Hepatitis AVaccine
TyphoidVaccine
Clinical data
Trade namesViVaxim, Hepatyrix, ViATIM
AHFS/Drugs.comUK Drug Information
Pregnancy
category
  • AU: B2
Routes of
administration
Intramuscular injection
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
Identifiers
CAS Number
ChemSpider
  • none

Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria. Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]

Society and culture

[edit]

Brand names

[edit]

The vaccine is distributed under various brand names in the European Union.[1]

References

[edit]
  1. ^ a b c List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) (PDF) (Report). European Medicines Agency (EMA). Retrieved 18 October 2020.
  2. ^ "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Archived from the original (PDF) on 15 July 2018. Retrieved 15 July 2018.
  3. ^ "VIVAXIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  4. ^ "Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine" (PDF). Retrieved 18 October 2020.
  5. ^ "Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine". Retrieved 18 October 2020.
  6. ^ "Vivaxim 1mL injection syringe composite pack". Therapeutic Goods Administration (TGA). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
  7. ^ "Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack" (PDF). Therapeutic Goods Administration (TGA). Retrieved 18 October 2020.[permanent dead link]
  8. ^ "ViATIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  9. ^ "ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 3 September 2019. Retrieved 18 October 2020.